Filing Details
- Accession Number:
- 0001477449-24-000048
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-05 16:11:16
- Reporting Period:
- 2024-03-01
- Accepted Time:
- 2024-03-05 16:11:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1477449 | Teladoc Health Inc. | TDOC | Services-Offices & Clinics Of Doctors Of Medicine (8011) | 043705970 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1599417 | J Richard Napolitano | C/O Teladoc Health, Inc., 2 Manhattanville Road, Suite 203 Purchase NY 10577 | Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-03-01 | 1,604 | $0.00 | 13,353 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-03-01 | 504 | $0.00 | 13,857 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-03-01 | 1,481 | $0.00 | 15,338 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-03-01 | 337 | $0.00 | 15,675 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-03-01 | 565 | $0.00 | 16,240 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-03-01 | 894 | $0.00 | 17,134 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-03-01 | 4,708 | $0.00 | 21,842 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-03-04 | 3,765 | $14.52 | 18,077 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Performance Stock Units | Acquisiton | 2024-03-01 | 4,814 | $0.00 | 4,814 | $0.00 |
| Common Stock | Performance Stock Units | Disposition | 2024-03-01 | 1,604 | $0.00 | 1,604 | $0.00 |
| Common Stock | Performance Stock Units | Acquisiton | 2024-03-01 | 1,515 | $0.00 | 1,515 | $0.00 |
| Common Stock | Performance Stock Units | Disposition | 2024-03-01 | 504 | $0.00 | 504 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2024-03-01 | 1,481 | $0.00 | 1,481 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2024-03-01 | 337 | $0.00 | 337 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2024-03-01 | 565 | $0.00 | 565 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2024-03-01 | 894 | $0.00 | 894 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2024-03-01 | 4,708 | $0.00 | 4,708 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,814 | No | 4 | A | Direct | ||
| 3,210 | No | 4 | M | Direct | ||
| 1,515 | No | 4 | A | Direct | ||
| 1,011 | No | 4 | M | Direct | ||
| 2,963 | No | 4 | M | Direct | ||
| 1,348 | No | 4 | M | Direct | ||
| 2,260 | No | 4 | M | Direct | ||
| 4,472 | No | 4 | M | Direct | ||
| 9,418 | No | 4 | M | Direct |
Footnotes
- Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
- Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
- Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
- Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
- The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- On March 1, 2024, the reporting person earned 4,614 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- On March 1, 2024, the reporting person earned 1,515 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- On May 1, 2023, the reporting person was granted 4,444 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- On March 1, 2022, the reporting person was granted 4,043 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- On April 1, 2022, the reporting person was granted 6,778 restricted stock units, vesting one-third on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- On June 1, 2022, the reporting person was granted 10,730 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- On March 3, 2023, the reporting person was granted 14,126 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Billionaire Hedge Funds
